Acuvax


Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

Acuvax Ltd (ASX: ACU) is in the process of acquiring Biolife Science Ltd, which is developing a vaccine for breast and gastric cancers. On 22 March 2013, Acuvax shareholders voted overwhlemingly to approve the acquisition of Biolife and to raise $5m to fund Phase 2 trials of the vaccine.

Category: Health & biotech
URL: http://www.acuvax.com.au
Operational Status: Active
ASX Listing Code (if applicable): ACU
Year of Commencement: 2001
Address:

Suite 4, 16 Ord Street, WEST PERTH, WA, AUSTRALIA, 6005

State: Western Australia
Overseas Operations: No
Twitter:
Facebook:
Linkedin:
Key Personnel:
Awards won:

Leave a Reply